OPAL Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
OPAL is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is trading below key moving averages, momentum is weak, and proprietary signals do not show a buy setup. With no recent news catalyst, neutral insider/hedge activity, and mixed analyst views, the current setup favors staying out rather than buying now.
Current price is 1.92 in pre-market, slightly above S1 at 1.957? Actually the quoted pre-market price is near that support zone and still below the pivot at 2.141, with resistance at 2.324 and 2.437. The trend is bearish: SMA_200 > SMA_20 > SMA_5, MACD histogram is -0.0224 and worsening, and RSI_6 at 25.713 suggests weak momentum. Overall, price action indicates a downtrend with no confirmed reversal. The stock trend model also points to negative near-term performance expectations.
B. Riley still keeps a Buy rating and sees upside to $4, reflecting confidence in the company's longer-term potential. The pre-market move is slightly positive, and open interest put-call ratio below 1 suggests some positioning is not overly bearish. The company may also benefit from refinancing and funding actions if executed well.
Goldman Sachs maintains a Sell rating, and B. Riley lowered its target from $5 to $4, showing fading near-term expectations. There is no recent news in the last week, so there is no fresh catalyst to drive the stock higher. Hedge funds and insiders are both neutral, and there is no recent congress or influential figure trading activity. Technicals remain bearish, and the model projects negative returns over the next day, week, and month.
Latest quarter financials were not provided, so there is no reliable quarterly growth assessment available from the data. The only financial-related note is analyst commentary that refinancing actions and expected funding needs through 2027 were incorporated into estimates, which suggests capital needs remain an important consideration.
Analyst sentiment is mixed to negative. B. Riley lowered its price target to $4 from $5 but kept a Buy rating. Goldman Sachs raised its target to $2.40 from $2.10 but kept a Sell rating. This shows the Wall Street view is divided, but the more cautious sell-side stance and target reduction indicate limited conviction for a near-term buy.
